Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5371 |
L-BUTHIONINE-(S,R)-SULFOXIMINE
L-Butionine sulfoximine,丁硫氨酸-亚砜亚胺 |
Others; Ferroptosis | Apoptosis; Others |
L-Buthionine-(S,R)-sulfoximine 是一种细胞渗透性和不可逆的 γ-谷氨酰半胱氨酸合成酶抑制剂,通过消耗 GSH 诱导细胞中的氧化应激,可降低细胞内谷胱甘肽的水平,其对黑色素瘤、乳腺卵巢癌标本的 IC50值分别为1.9 μM、8.6 μM 和29 μM。 | |||
T7708 |
DL-Buthionine-(S,R)-sulfoximine
Butionine sulfoximine,丁基硫,NSC 381100,D,L-Buthionine-(S,R)-sulfoximine |
Others; Ferroptosis | Apoptosis; Others |
DL-Buthionine-(S,R)-sulfoximine (Butionine sulfoximine) 是 γ-谷氨酰半胱氨酸合成酶的抑制剂,用于治疗实体瘤。 | |||
T65554 |
cholesterol-absorption inhibitor Intermediate 2
|
Others | Others |
cholesterol-absorption inhibitor Intermediate 2 是一种有效且具有口服活性的胆固醇吸收抑制剂,可降低血液中胆固醇含量。 | |||
T29521 |
Absouline
|
||
Absouline is a biochemical. | |||
T126378 |
Isoabsouline
|
||
Isoabsouline 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T126378。 | |||
T31899 |
FY26
FY 26,FY-26 |
||
FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer ac | |||
T37248 |
Pantothenate Kinase Inhibitor
|
||
Pantothenate Kinase Inhibitor (PANKi) is a reversible inhibitor of pantothenate kinase (PanK; IC50s = 70, 92, and 25 nM for PanK1β, PanK2, and PanK3, respectively), the rate-limiting enzyme in the synthesis of coenzyme A .1It binds to the ATP-PanK3 complex with an apparent binding constant of 300 nM and exhibits mixed-type inhibition with respect to ATP and pantothenate. PANKi inhibits CoA biosynthesis in C3A cells (IC50= 0.9 μM) with no effect on cell viability when used at concentrations up to... |